Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
ALAIN01-Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-beta-1b: a case report.
Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.
Therapeutic Testosterone Administration Preserves Excitatory Synaptic Transmission in the Hippocampus during Autoimmune Demyelinating Disease.
Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.
No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
Calcitriol Modulates the CD46 Pathway in T Cells.
Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis.
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Mycoplasma pneumonia seroposivity in Iranian patients with relapsing-remitting multipl sclerosis: a randomized case-control study.
Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis.
Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
Puma, but not noxa is essential for oligodendroglial cell death.
Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
Laquinimod for multiple sclerosis.
The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.
Double blind placebo-controlled Phase I/II clinical trial of idebenone in patients with primary progressive multiple sclerosis (IPPoMS)
Generic Midamor
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.
A practical review of the neuropathology and neuroimaging of multiple sclerosis.
Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with MS.
Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b.
Pages
« first
‹ previous
…
96
97
98
99
100
101
102
103
104
…
next ›
last »